China Healthwise Holdings Ltd. Reports Decline in Chinese Health Products Revenue to HK$50.98M and Net Profit of HK$7.84M for First Half of 2025
Reuters
Aug 27, 2025
China Healthwise Holdings Ltd. Reports Decline in Chinese Health Products Revenue to HK$50.98M and Net Profit of HK$7.84M for First Half of 2025
China Healthwise Holdings Limited has announced its unaudited interim results for the six months ended 30 June 2025. The Group reported a total revenue of HK$51.06 million, a decrease from HK$60.93 million in the same period of 2024. Revenue from the sale of Chinese health products was HK$50.98 million, down from HK$60.43 million in the previous year. The money lending business generated HK$0.32 million, a decline from HK$0.61 million. The segment for investment in financial instruments recorded a loss of HK$0.24 million, compared to a loss of HK$0.11 million the year before. The Group's segment profit before income tax totaled HK$7.84 million, contrasting with a segment loss of HK$4.40 million from Chinese health products, a profit of HK$0.87 million from the money lending business, and a profit of HK$11.37 million from investments in financial instruments. No outlook or guidance updates were provided in the announcement.
Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. China Healthwise Holdings Ltd. published the original content used to generate this news brief on August 27, 2025, and is solely responsible for the information contained therein.
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.